Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Medical Chart Review of Healthcare Costs in Patients with Systemic Amyloid Light Chain Amyloidosis By Mayo 2012 Stage in the United States

Morie A. Gertz, Heather J. Landau, Vaishali Sanchorawala, Manisha Bhutani, Jeffrey A. Zonder, Michael Rosenzweig, Gray Magee, Cynthia Campos, Irina Yermilov, Eunice Chang, Michael S. Broder, Preeti Bajaj

Blood (2024) 144 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2024-206132

Published: 2024

Journal Articles

U.S. Expert Consensus on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment in Chronic Phase Chronic Myeloid Leukemia (CML)

Ehab L. Atallah, Michael S. Broder, Onyee Chan, Hannah Dalglish, Kathryn E. Flynn, Jeffrey Gilreath, Marisa Hine, Anthony M. Hunter, Michael J. Mauro, Javier Pinilla-Ibarz, Lindsay A.M. Rein, Neil P. Shah, Evan Stemper, Srinivas K Tantravahi, Jay Yang

Blood (2024) 144 (Supplement 1): 5052.

https://doi.org/10.1182/blood-2024-194617

Published: 2024

Journal Articles

Healthcare Utilization Among Patients with Advanced Systemic Light Chain Amyloidosis

Morie A. Gertz, Rafat Abonour, Sarah N. Gibbs, Muriel Finkel, Heather Landau, Suzanne Lentzsch, Grace Lin, Anuj Mahindra, Tiffany P. Quock, Cara A. Rosenbaum, Michael Rosenzweig, Surbhi Sidana, Sascha A. Tuchman, Ronald Witteles, Irina Yermilov, Michael S. Broder

Blood (2022) 140 (Supplement 1): 13129–13131.

https://doi.org/10.1182/blood-2022-156832

Published: 2022

Journal Articles

Healthcare Resource Utilization and Costs of Patients with AL Amyloidosis: An Analysis of Hospitalizations in the Premier Database

Tiffany P. Quock, Eunice Chang, Katalin Bognar, Anita D'Souza, Michael S Broder

Blood (2021) 138 (Supplement 1): 4724.

https://doi.org/10.1182/blood-2021-146983

Published: 2021

Journal Articles

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method

Adam Cuker, MD, Jenny M. Despotovic, DO, Rachael F. Grace, MD, Caroline Kruse, Michele P. Lambert, MD MSTR, Howard Liebman, MD, Roger M. Lyons, MD, Keith R McCrae, MD, Vinod A. Pullarkat, MD, Jeffrey Wasser, MD, David Beenhouwer, MD, Sarah N Gibbs, MPH, Irina Yermilov, MD MPH, MS, Michael S Broder, MD MSHS

Blood (2020) 136 (Supplement 1): 6–8.

https://doi.org/10.1182/blood-2020-133262

Published: 2020

Journal Articles

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Nirmish Shah, David Beenhouwer, Michael S Broder, MD MSHS, Lanetta Bronte-Hall, Laura De Castro, MD MHSc, Sarah N Gibbs, Victor R Gordeuk, MD, Julie Kanter, MD, Elizabeth S Klings, MD, Thokozeni Lipato, MD, Deepa Manwani, MD, Brigid Scullin, Irina Yermilov, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 415.

https://doi.org/10.1182/blood-2019-121556

Published: 2019

Journal Articles

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Michael S Broder, MD MSHS, Qiufei Ma, PhD, Tingjian Yan, PhD, Eunice Chang, PhD, Lamis K. Eldjerou, MD, Yanni Hao, PhD, David Kuzan, MD, Jie Zhang, PhD

Blood (2019) 134 (Supplement_1): 4719.

https://doi.org/10.1182/blood-2019-122587

Published: 2019

Journal Articles

Real-World Burden of Comorbidities in US Patients with AL Amyloidosis

Tiffany P. Quock, PhD MS, Jessie T. Yan, PhD, Eunice Chang, PhD, Spencer D Guthrie, MBA, Michael S. Broder, MD MSHS

Blood (2017) 130 (Supplement 1): 5595.

https://doi.org/10.1182/blood.V130.Suppl_1.5595.5595

Published: 2017

Journal Articles

Epidemiology of AL Amyloidosis in a US Commercially Insured Population

Tiffany P. Quock, PhD MS, Jessie T. Yan, PhD, Eunice Chang, PhD, Spencer D Guthrie, MBA, Michael S. Broder, MD MSHS

Blood (2017) 130 (Supplement 1): 5335.

https://doi.org/10.1182/blood.V130.Suppl_1.5335.5335

Published: 2017

Journal Articles

Healthcare Utilization and Costs in Commercially Insured Patients with AL Amyloidosis

Tiffany P. Quock, PhD MS, Jessie T. Yan, PhD, Eunice Chang, PhD, Spencer D Guthrie, MBA, Michael S. Broder, MD MSHS

Blood (2017) 130 (Supplement 1): 4659.

https://doi.org/10.1182/blood.V130.Suppl_1.4659.4659

Published: 2017

Journal Articles

Early Treatment Initiation in Myelodysplastic Syndromes (MDS) Produces Higher Rate of and Earlier Transfusion Independence

Christopher R. Cogle, MD, Sheila R. Reddy, PhD RPh, Eunice Chang, PhD, Elya Papoyan, MPH, Michael S. Broder, MD MSHS, Michael McGuire, PharmD, Gary Binder, MBA

Blood (2016) 128 (22): 395.

https://doi.org/10.1182/blood.V128.22.395.395

Published: 2016

Journal Articles

Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens

Tiffany P. Quock, PhD MS, Michael S. Broder, MD MSHS, Eunice Chang, PhD, Sheila R. Reddy, PhD MS, RPh, Sally Arai, MD, Rajni Agarwal-Hashmi, MD, Kathleen F. Villa, MS

Blood (2015) 126 (23): 3270.

https://doi.org/10.1182/blood.V126.23.3270.3270

Published: 2015

Journal Articles

Incidence of First-Line and Second-Line Myelodysplastic Syndrome in a US Commercial Claims Database

Christopher R. Cogle, MD, Sandra E. Kurtin, RN, MS, AOCN, ANP-C, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS

Blood (2014) 124 (21): 6008.

https://doi.org/10.1182/blood.V124.21.6008.6008

Published: 2014

Journal Articles

Healthcare Resource Utilization and Costs Among Patients with Myelodysplastic Syndrome Who Failed 1 st -Line Therapy

Christopher R. Cogle, MD, Sudipto Mukherjee, MD MPH, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS

Blood (2014) 124 (21): 2627.

https://doi.org/10.1182/blood.V124.21.2627.2627

Published: 2014

Journal Articles

Treatment Patterns Among Patients with Myelodysplastic Syndromes: Observations of 1 st -Line Therapy, Discontinuation and the Need of Additional Therapies

Sudipto Mukherjee, MD MPH, Christopher R. Cogle, MD, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS

Blood (2014) 124 (21): 2598.

https://doi.org/10.1182/blood.V124.21.2598.2598

Published: 2014

Journal Articles

Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage

MW Saville, K Taga, A Foli, S Broder, G Tosato, R Yarchoan

Blood (1994) 83 (12): 3591–3599.

https://doi.org/10.1182/blood.V83.12.3591.3591

Published: 1994

Journal Articles

Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages

CF Perno, DA Cooney, WY Gao, Z Hao, DG Johns, A Foli, NR Hartman, R Calio, S Broder, R Yarchoan

Blood (1992) 80 (4): 995–1003.

https://doi.org/10.1182/blood.V80.4.995.995

Published: 1992

Journal Articles

Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]

R Yarchoan, JM Pluda, CF Perno, H Mitsuya, S Broder

Blood (1991) 78 (4): 859–884.

https://doi.org/10.1182/blood.V78.4.859.859

Published: 1991

Journal Articles

Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection [see comments]

JM Pluda, R Yarchoan, PD Smith, N McAtee, LE Shay, D Oette, M Maha, SM Wahl, CE Myers, S Broder

Blood (1990) 76 (3): 463–472.

https://doi.org/10.1182/blood.V76.3.463.463

Published: 1990

Journal Articles

2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells

Z Spigelman, R Duff, GP Beardsley, S Broder, D Cooney, NR Landau, H Mitsuya, B Ullman, R McCaffrey

Blood (1988) 71 (6): 1601–1608.

https://doi.org/10.1182/blood.V71.6.1601.1601

Published: 1988

NARROW

A Medical Chart Review of Healthcare Costs in Patients with Systemic Amyloid Light Chain Amyloidosis By Mayo 2012 Stage in the United States

U.S. Expert Consensus on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment in Chronic Phase Chronic Myeloid Leukemia (CML)

Healthcare Utilization Among Patients with Advanced Systemic Light Chain Amyloidosis

Healthcare Resource Utilization and Costs of Patients with AL Amyloidosis: An Analysis of Hospitalizations in the Premier Database

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Recommendations Based on the RAND/UCLA Modified Delphi Panel Method

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Real-World Burden of Comorbidities in US Patients with AL Amyloidosis

Epidemiology of AL Amyloidosis in a US Commercially Insured Population

Healthcare Utilization and Costs in Commercially Insured Patients with AL Amyloidosis

Early Treatment Initiation in Myelodysplastic Syndromes (MDS) Produces Higher Rate of and Earlier Transfusion Independence

Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens

Incidence of First-Line and Second-Line Myelodysplastic Syndrome in a US Commercial Claims Database

Healthcare Resource Utilization and Costs Among Patients with Myelodysplastic Syndrome Who Failed 1 st -Line Therapy

Treatment Patterns Among Patients with Myelodysplastic Syndromes: Observations of 1 st -Line Therapy, Discontinuation and the Need of Additional Therapies

Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage

Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages

Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]

Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection [see comments]

2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only